Recall Register

Food, drugs, devices › Abbott Molecular, Inc.

Device recall: Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use

FDA enforcement event 91001 · Class II · initiated 12 Oct 2022 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordDes Plaines, IL

Abbott Molecular, Inc. (Des Plaines, IL) initiated this device recall on 12 Oct 2022; FDA lists 1 product record under event 91001, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 839 device enforcement events initiated in 2022 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Abbott Molecular, Inc. has 20 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Abbott Molecular, Inc., Des Plaines, IL.

Reason for recall

"Abbott has identified potential performance issues for the Alinity m System software version 1.6.5: 1) In a unique scenario, the waste chute flapper was found to not open when the Systems Solution drawer was closed and locked. It was found that the software will cause the flapper door to stay in the closed position when the drawer is closed and locked if the flapper had previously been moved out…"

Distribution

"Worldwide distribution."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0268-2023Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use883 unitsClass IIOngoing30 Nov 2022

Context

88%of 2022 device events are Class II839 events that year
1product record in this eventfirm median: 1
20events on this register for the firm

Other enforcement events for Abbott Molecular, Inc.

InitiatedProduct (first record)TypeClassRecords
28 Apr 2025Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time reverse transcription (DeviceClass II2
20 Mar 2025The Alinity m System is designed to automate the steps for nucleic acid testing. Model Numbers included in this recall aDeviceClass II1
12 Sep 2024Abbott Alinity m HPV AMP Kit, used with the Alinity m System, product codes: a) REF 09N15-095; b) REF 09N15-090; c) REF DeviceClass II2
20 Mar 2024Alinity m System, Part Number: 08N53-002DeviceClass II1
1 Feb 2024In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13DeviceClass III3
30 Oct 2023Alinity m HCV AMP kit, List (REF) Numbers: a) 08N50-095 and b) 08N50-090. The Alinity m HCV assay is an in vitro reverseDeviceClass II1
9 Dec 2022Alinity m System. The Alinity m System is designed to automate the steps for nucleic acid testing, which includes sampleDeviceClass II1
22 Nov 2022Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-096DeviceClass II2
11 Nov 2022Abbott Alinity m System, REF 08N53-002, containing Amplification Detetction Unit (ADU) #4.DeviceClass II1
19 Aug 2022Abbott Alinity m SARS-CoV-2 CTRL Kit, REF 09N78-085, each kit contains 12 x 1.3mL CTRL - and 12 x 1.3 mL CTRL +, For In DeviceClass II1

All 20 events for Abbott Molecular, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Abbott has identified potential performance issues for the Alinity m System software version 1.6.5: 1) In a unique scenario, the waste chute flapper was found to not open when the Systems Solution drawer was closed and locked. It was found that the software will cause the flapper door to stay in the closed position when the drawer is closed and locked if the flapper had previously been moved out…"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.